Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-17

Clinical Trial Update: A Clinical Research Study Testing Ropinirole Treatment for Restless Legs Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ropinirole for restless legs syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropinirole (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Restless Legs Syndrome (RLS), Restless Legs Syndrome | Phase 3 | Status: COMPLETED